Imaging Protocol
This page describes how images are captured for psoriasis clinical trials using Legit.Health, and how a single standardised capture set produces the PASI. It also covers image quality control, patient preparation, and site standardisation.
The example images on this page are synthetic dermatology imagery used for illustration; they are not patient records.
Image capture hardware compatibility
Smartphone-based capture
Legit.Health uses standard smartphone cameras for image acquisition. No specialised photography equipment is required.
Traditional clinical photography often relies on dedicated imaging systems, which require per-site hardware, per-site calibration, and significant rental or purchase costs. Smartphone-based capture eliminates these costs while maintaining the image quality needed for AI scoring.
The Legit.Health mobile application guides investigators through the capture process with visual perspective silhouettes, real-time DIQA quality checks, and immediate feedback on image adequacy.
Camera-based capture
Smartphones are the default input, but they are not the only one. The same AI also scores images from professional, camera-based photography systems, which capture higher-resolution, more consistent images than a smartphone. Sponsors that already run standardised imaging at their sites can keep that setup and still obtain automated Legit.Health endpoints.
For studies that require standardised photography hardware, Legit.Health partners with QuantifiCare, a specialist in standardised 2D and 3D clinical imaging for dermatology trials.
DIQA: Dermatology Image Quality Assessment
What is DIQA?
DIQA (Dermatology Image Quality Assessment) is an AI-powered image quality assessment algorithm that evaluates every captured image in real time before it is accepted for analysis. It was developed by Legit.Health and published in the Journal of the American Academy of Dermatology (Hernández Montilla et al., 2023).
What DIQA evaluates
| Quality dimension | What it checks | Why it matters |
|---|---|---|
| Focus | Sharpness of the image; absence of motion blur | Out-of-focus images can obscure small lesions, leading to undercounting |
| Lighting | Adequate, even illumination; absence of harsh shadows or glare | Poor lighting creates shadows that mimic or hide lesions |
| Framing | Correct anatomical region captured at the required angle | Incorrect framing means the AI analyses the wrong area |
| Resolution | Sufficient pixel density for lesion detection | Low resolution makes small features undetectable |
How it works in the workflow
- The investigator or patient captures an image through the mobile application
- DIQA evaluates the image immediately (sub-second processing)
- If the image passes: it is accepted and queued for AI scoring
- If the image fails: the person capturing the image receives immediate feedback explaining the quality issue and must recapture
The DIQA pass/fail threshold is configurable per study protocol. Sponsors can choose stricter thresholds for pivotal studies (rejecting more images to ensure the highest quality) or more lenient thresholds for real-world evidence studies.
Pose and framing verification
Beyond image quality, the platform verifies that the patient is positioned according to the protocol for each perspective. Using body and pose detection, it confirms that the correct region is framed and oriented as the on-screen silhouette requires. If the body does not match the instructions, the image is rejected in real time and the user is prompted to recapture, before the photograph is ever submitted for scoring.
This matters more in psoriasis than in most indications, because the affected area component of the PASI is computed per body region: a mispositioned perspective does not just degrade an image, it attributes affected skin to the wrong region. Verifying the pose at capture keeps every perspective comparable across visits and sites, which reduces protocol deviations and prevents unusable images from surfacing as missing data at database lock, including in decentralised, patient-led capture.
Click on the buttons to open the camera or to upload a file.

Your body is not correctly positioned according to the instructions.
The app rejects a mispositioned capture in real time and prompts the user to recapture. Placeholder image.
Standard capture protocol
The default protocol captures 8 images: 4 full-body perspectives for affected-area segmentation across the four PASI regions, and 4 close-ups for intensity-sign scoring. The app guides the investigator or patient through each perspective in order, with silhouette guidance and a real-time DIQA quality check before moving to the next.
8 images (4 perspectives + 4 close-ups)
Perspectives
Close-ups








The four regions shown in the diagram above are where close-ups are most often taken, not a fixed list of body sites. Psoriasis does not appear in the same places in every patient, so the close-up set follows the plaques the patient actually has: where a region is clear, the close-up moves to an area that carries disease. The four full-body perspectives are fixed, because the affected area has to be measured across the whole body, but the close-ups are the flexible half of the protocol. Whichever sites are chosen at baseline are the ones captured at every later visit, so that the same plaques are compared over time.
Capture time
The full 8-image protocol (4 perspectives + 4 close-ups) takes approximately 3 to 5 minutes using the guided Legit.Health mobile application.
When a body area shows more than one plaque, the close-up captures the single most significant lesion for that area, meaning the one judged most representative by size and severity at the discretion of the person capturing the image.
Patient preparation
- Remove clothing from the area being photographed
- No emollient, keratolytic or topical treatment applied within 2 hours of the visit (unless protocol specifies otherwise)
- Hair pinned back for scalp, face and neck assessments
- Remove jewellery from the area being photographed
- Neutral, well-lit background; standard smartphone flash or even natural light

Loose hair falls over the shoulders and upper back, hiding affected skin. Placeholder image.

Hair pinned up, so the neck, shoulders and back are fully visible. Placeholder image.
Environmental conditions
- Patient positioning: Standing comfortably for the full-body perspectives, remaining still during capture
- Background: Neutral, non-reflective background, essential for body segmentation
- Lighting: Well-lit environment with even illumination. Natural light or smartphone flash can be used. Avoid harsh directional lighting that creates deep shadows, which distorts erythema assessment.
- Distance: Approximately 1.5 to 2 metres for the full-body perspectives and 30 to 50 cm for the close-ups

Harsh, uneven light blows out the highlights and erases skin detail. Placeholder image.

Even, diffuse lighting on a neutral background renders lesions faithfully. Placeholder image.
The most important principle is consistency: the same lighting conditions, the same distance, the same angles, and the same patient preparation at every visit. Consistent capture conditions ensure that score changes between visits reflect actual clinical changes, not variations in image acquisition.
Local and global scoring
Because the affected area is measured from the photographs, only the areas that are captured contribute to the score. The scope of the score follows the scope of the capture, and both scopes are valid outputs by design:
- Global PASI: captured from the full standard set. The full-body perspectives give the affected area for each of the four PASI regions, so the platform reports the whole-body PASI on the standard 0 to 72 scale.
- Local PASI: when a protocol captures only close-ups of one or more target lesions, without the full-body perspectives, the platform scores the intensity signs on the imaged areas and reports a local PASI for those areas. This is the score of the region photographed, not the whole-body global score.
Local scoring is designed for target-lesion protocols, where the endpoint is the evolution of a defined index plaque rather than whole-body severity. For global endpoints, the standard full-body set is built to cover every clinically relevant area; the DIQA quality gate confirms that all required perspectives are present before submission, and in decentralised trials patient-guided capture provides the same coverage.
Anonymisation
All photographs are anonymised automatically before they are stored or exported. Beyond the face, the system also masks other potentially identifying marks, such as tattoos, so that neither facial features nor distinctive body markings can be used to re-identify the patient.

Facial features masked. Placeholder image.

Identifying tattoo blurred. Placeholder image.